Keizman, D., Ish-Shalom, M., Huang, P., Eisenberger, M. A., Pili, R., Hammers, H., & Carducci, M. A. (2011). The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival, and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma.

Keizman, Daniel, Maya Ish-Shalom, Peng Huang, Mario A. Eisenberger, Roberto Pili, Hans Hammers, und Michael A. Carducci. The Association of Pre-treatment Neutrophil to Lymphocyte Ratio With Response Rate, Progression Free Survival, and Overall Survival of Patients Treated With Sunitinib for Metastatic Renal Cell Carcinoma. 2011.

Keizman, Daniel, et al. The Association of Pre-treatment Neutrophil to Lymphocyte Ratio With Response Rate, Progression Free Survival, and Overall Survival of Patients Treated With Sunitinib for Metastatic Renal Cell Carcinoma. 2011.